Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
42.45
-0.08 (-0.19%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Company Description
Veracyte, Inc. operates as a diagnostics company in the United States and internationally.
The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis.
It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008.
Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Veracyte, Inc.
| Country | United States |
| Founded | 2006 |
| IPO Date | Oct 30, 2013 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 755 |
| CEO | Marc Stapley |
Contact Details
Address: 6000 Shoreline Court, Suite 300 South San Francisco, California 94080 United States | |
| Phone | 650 243 6300 |
| Website | veracyte.com |
Stock Details
| Ticker Symbol | VCYT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001384101 |
| CUSIP Number | 92337F107 |
| ISIN Number | US92337F1075 |
| Employer ID | 20-5455398 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Marc A. Stapley | Chief Executive Officer and Director |
| Rebecca Chambers | Executive Vice President and Chief Financial Officer |
| Dr. Phillip G. Febbo M.D. | Chief Scientific and Medical Officer |
| Dr. John Leite Ph.D. | Global Chief Commercial Officer |
| Dr. Keith Gligorich Ph.D. | Senior Vice President of Global Operations |
| Jonathan Wygant | Vice President and Chief Accounting Officer |
| Steven French | Senior Vice President and Chief Information Officer |
| Kelly Gura | Director of Investor Relations |
| Karen Possemato | Senior Vice President of Corporate Marketing, Communications and Commercial Operations |
| Tracy Ward | Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 4, 2026 | 144 | Filing |
| Sep 4, 2026 | 144 | Filing |
| Sep 4, 2026 | 144 | Filing |
| Sep 1, 2026 | 144 | Filing |
| Jul 31, 2026 | 10-Q | Quarterly Report |
| Jul 30, 2026 | 8-K | Current Report |
| Jun 18, 2026 | 144 | Filing |
| Jun 11, 2026 | 8-K | Current Report |
| Jun 10, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 5, 2026 | SCHEDULE 13G/A | Filing |